We are Global Leaders & Expanding says Rahul Nachane, MD, NGL Fine-Chem Excl @IBMTVLIVE

Summary

Rahul G, Managing Director of NGL Fine Cam Limited, discusses the company's 43-year journey specializing in APIs for the veterinary pharmaceutical sector. With a focus on farm animals, NGL Fine Cam has carved a niche in the market, exporting to 55 countries and holding significant market share in its top products. The company, recognized in Forbes' Best Under a Billion list, is financially robust with a 15% average EBITDA over the last decade. Rahul highlights the company's high-quality standards, ISO certifications, and European guidelines compliance, emphasizing future growth potential despite current challenges like pricing pressures and competition from China.

Takeaways

• 😀 Rahul G is the Managing Director of NGL Fine-Cam Limited, a company that manufactures APIs (Active Pharmaceutical Ingredients).
• 🏭 NGL Fine-Cam Limited specializes in veterinary pharmaceuticals, focusing on APIs for farm animals like cows, horses, goats, and sheep.
• 🌐 The company's products are exported to 55 countries, with a strong emphasis on the global market, particularly in the top five products where they hold more than 50% market share.
• 🏅 NGL Fine-Cam Limited has been recognized by Forbes as one of Asia's Best Under a Billion companies, featuring in their list in 2015, 2016, and 2021.
• 📈 The company has a robust financial standing, reporting profits of over 15% EBITDA on average for the last 10 years.
• 🔬 NGL Fine-Cam has a dedicated R&D team of about 40 scientists working on new and innovative products.
• 🌟 The company meets high-quality standards, including ISO certifications and European guidelines for pharmaceutical manufacturing.
• 💹 NGL Fine-Cam is planning a significant expansion, investing 200 crores over the next two years, with a focus on entering the US and European markets.
• 📊 The veterinary industry is growing rapidly, with a strong potential for growth in companion animal healthcare as standards of living improve globally.
• 📈 Despite facing competition and pricing challenges, especially from China, the company is optimistic about future growth and opportunities in the animal health sector.

Q & A

What is the primary business of NGL Fine-Cam Limited?

NGL Fine-Cam Limited is a company that manufactures APIs (Active Pharmaceutical Ingredients). They sell these APIs to other pharmaceutical companies who then make tablets, capsules, and injections.

How long has NGL Fine-Cam Limited been in operation?

NGL Fine-Cam Limited is close to 43 years old and has been an API company throughout its journey.

What was the initial focus of NGL Fine-Cam Limited when it started?

Initially, NGL Fine-Cam Limited focused on making human pharmaceuticals, but for the last 27-28 years, they have specialized mainly in Veterinary Pharmaceuticals.

What types of animals does NGL Fine-Cam Limited primarily serve with their products?

NGL Fine-Cam Limited primarily serves farm animals such as cows, horses, goats, and sheep with their range of products.

How many different APIs does NGL Fine-Cam Limited produce today?

NGL Fine-Cam Limited makes almost about 30 different APIs today, with close to 28 of them being for animal or veterinary use, and two for human use.

What makes NGL Fine-Cam Limited unique in the Indian pharmaceutical industry?

NGL Fine-Cam Limited is unique because it is one of the few companies in India that is focused exclusively on Animal Health, which is more popular across the world.

Has NGL Fine-Cam Limited been recognized for its performance?

Yes, NGL Fine-Cam Limited has been listed in Forbes' 'Best Under a Billion' in Asia's best billion companies in 2015, 2016, and 2021, which is a major achievement.

What is the export to local sale ratio for NGL Fine-Cam Limited?

The export to local sale ratio for NGL Fine-Cam Limited is close to 3 to 1, meaning almost 75% of what they produce is exported.

How many countries does NGL Fine-Cam Limited export to?

NGL Fine-Cam Limited exports its products to almost 55 countries across the world.

What are the top five products in which NGL Fine-Cam Limited is a global leader?

The script does not specify the exact names of the top five products, but it mentions that NGL Fine-Cam Limited holds more than 50% market share in those products on a global scale.

What quality certifications does NGL Fine-Cam Limited have?

NGL Fine-Cam Limited has ISO certification 9,1 for Quality, 14,1, and 45,000 for health and safety, and they also meet the European guidelines for pharmaceutical manufacturing known as the IC guidelines.

What is the financial strength of NGL Fine-Cam Limited?

NGL Fine-Cam Limited has been reporting profits of over 15% EBITDA on average for the last 10 years, indicating that they are financially strong.

What are the company's expansion plans?

NGL Fine-Cam Limited plans to invest close to 200 crores over the next 2 years to expand their capacity, with 160 crores going into a green field venture to cater to the US and European markets, and another 40 crores to expand capacity in existing markets.